About
CannRx develops proprietary science-based cannabis technologies. The company specializes in sleep and pain research, as well as on developing products for oncology support, Parkinson's disease, women's health, and recreational products for the sports industry. The company's ican.sleep is a proprietary formulation that targets sleep disorders. The product has undergone extensive in-vivo trials in predictive pharmaceutical models. CannRx has also performed extensive in-vivo testing of a pain management formulation, which has demonstrated significant and rapid relief of pain. CannRx's Vapor Capture Technology is an extraction technology designed specifically for the cannabis plant. The commercialized product provides a pre-activated, highly bio-available cannabis extract with a unique cannabinoid/terpene profile. The company is also creating a patented nanoparticle technology to solubilize cannabinoids and terpenes. The process inserts the important cannabis compounds into everyday proteins, resulting in highly soluble and stable nanoparticles. CannRx is a subsidiary of Izun Pharmaceuticals Corporation, a company in the boutique pharmaceutical area of botanical medicine.
Q&A
- What is CannRx's primary focus?
- CannRx specializes in developing proprietary science-based cannabis technologies, with a focus on sleep and pain research, and products for oncology support, Parkinson's disease, women's health, and the sports industry.
- What is the current operational status of CannRx?
- CannRx is currently inactive and ceased to operate in May 2022.
- When was CannRx founded?
- CannRx was founded in January 2017.
- What is CannRx's employee count?
- CannRx has an employee count in the 1-10 range.
- What is CannRx's primary sector?
- CannRx's primary sector is Health Tech & Life Sciences.
- Does CannRx have any patented technology?
- Yes, CannRx has patented nanoparticle technology designed to solubilize cannabinoids and terpenes.
- What is ican.sleep?
- ican.sleep is a proprietary formulation developed by CannRx that targets sleep disorders and has undergone extensive in-vivo trials.
- What is CannRx's Vapor Capture Technology?
- CannRx's Vapor Capture Technology is an extraction technology specifically for cannabis, providing a pre-activated, highly bio-available cannabis extract.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cannrx.com/ |
|---|
Identifiers & details
| Founded | 2017-1 |
|---|---|
| Employees (exact) | 6 |
| Offices | New York |
| Status reason | Non Active, May 2022 ceased to operate |